Voloridge Investment Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-40,010
| Closed | -$420K | – | 1340 |
|
|
2024
Q3 | $420K | Sell |
40,010
-38,426
| -49% | -$403K | ﹤0.01% | 1098 |
|
|
2024
Q2 | $918K | Sell |
78,436
-157,526
| -67% | -$1.84M | ﹤0.01% | 1063 |
|
|
2024
Q1 | $4.97M | Buy |
235,962
+198,242
| +526% | +$4.18M | 0.02% | 663 |
|
|
2023
Q4 | $677K | Buy |
+37,720
| New | +$677K | ﹤0.01% | 995 |
|
|
2022
Q1 | – | Sell |
-13,372
| Closed | -$437K | – | 1657 |
|
|
2021
Q4 | $437K | Sell |
13,372
-75,032
| -85% | -$2.45M | ﹤0.01% | 1423 |
|
|
2021
Q3 | $3.71M | Buy |
+88,404
| New | +$3.71M | 0.02% | 806 |
|
|
2021
Q1 | – | Sell |
-12,224
| Closed | -$554K | – | 1617 |
|
|
2020
Q4 | $554K | Buy |
+12,224
| New | +$554K | ﹤0.01% | 1105 |
|
|
2020
Q3 | – | Sell |
-44,692
| Closed | -$1.65M | – | 1462 |
|
|
2020
Q2 | $1.65M | Buy |
44,692
+37,433
| +516% | +$1.38M | 0.02% | 683 |
|
|
2020
Q1 | $235K | Buy |
+7,259
| New | +$235K | 0.01% | 923 |
|
|
2019
Q1 | – | Sell |
-8,893
| Closed | -$373K | – | 1041 |
|
|
2018
Q4 | $373K | Sell |
8,893
-32,449
| -78% | -$1.36M | 0.02% | 357 |
|
|
2018
Q3 | $3.12M | Buy |
+41,342
| New | +$3.12M | 0.07% | 178 |
|